Table 3

Factors associated with a change in HbA1c

	Sitagliptin		Voglibose
	rs	p Value	rs	p Value
Baseline
Body weight (kg)	−0.051	0.577	−0.082	0.374
Body mass index	−0.142	0.126	−0.08	0.390
Fasting plasma glucose (mg/dL)	−0.113	0.222	0.107	0.246
1,5 AG (%)	0.338	0.000	−0.034	0.714
HbA1c (%)	−0.589	0.000	−0.121	0.185
Total cholesterol (mg/dL)	0.050	0.588	0.009	0.948
Fasting serum insulin (IU/L)	−0.092	0.328	−0.079	0.392
CPR (ng/mL)	−0.101	0.275	−0.004	0.965
HMW adiponectin (µg/mL)	0.223	0.015	0.137	0.137
CPI	−0.048	0.609	−0.038	0.684
HOMAIR	−0.128	0.171	0.114	0.222
HOMA-β	−0.016	0.861	0.033	0.722
EPA (ng/mL)	−0.064	0.490	0.062	0.502
DHA (ng/mL)	−0.077	0.118	−0.078	0.396
Change from baseline
ΔFPG	0.386	0.000	0.421	0.000
ΔBW	0.212	0.020	0.047	0.609
ΔBMI	0.206	0.025	0.058	0.533
ΔALP	0.269	0.003	0.187	0.042
ΔTC	0.231	0.011	−0.062	0.502
ΔLDLC	0.266	0.004	0.151	0.103
ΔTG	0.084	0.362	−0.152	0.098
ΔHMW adiponectin	−0.310	0.001	−0.346	0.000
ΔHOMA-IR	0.233	0.012	0.105	0.262
ΔHOMA-β	−0.304	0.001	−0.222	0.016
ΔSUIT index	−0.377	0.000	−0.261	0.004
ΔQUICKI	−0.185	0.047	−0.175	0.060
ΔCPI	−0.235	0.011	−0.156	0.091
ΔProinsulin insulin ratio	0.199	0.046	0.177	0.094
ΔEPA	−0.010	0.914	−0.062	0.502
ΔDHA	0.073	0.430	−0.065	0.482

AG, anhydroglucitol; ALP, alkaline phosphatase; BMI, body mass index; BW, body weight; CPR, C-peptide immunoreactivity; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment-β; HMW, high molecular weight; LDLC, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.